Type: Oral
Session: 112. Thalassemia and Globin Gene Regulation: We're Going to Catch a Big One: Towards Targeted Therapies in Thalassemia
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Sickle Cell Disease, Translational Research, Thalassemia, Hemoglobinopathies, Hematopoiesis, Diseases, Biological Processes, Molecular biology
When both MBD2 and MBD3 were knocked out in HUDEP-2 cells, over 90% HBG/ (HBG+HBB) RNA levels were observed, similar to the levels observed with knockout of both LRF and BCL11A. However, the increase in HBG/(HBG+HBB) RNA ratio and corresponding HbF/ (HbF+HbA) ratio were due primarily to a 4-5-fold decrease in HBB RNA and protein, as the level of HBG RNA was the same or slightly less than in MBD2 KO cells.Chromatin conformation capture (3C) assays showed that combined depletion of MBD2 and MBD3 resulted in significantly decreased interaction of the Locus Control Region (LCR) with the HBB gene, increased LCR interaction with the BGLT3 locus and a very large increase in interaction of the 3’ beta globin locus enhancer with the HBB gene. These results demonstrate that MBD3-NuRD plays a critical role in the interaction of the LCR with the HBB gene to maintain its high level of expression in adult erythroid cells.
Depletion of LRF in MBD2 KO HUDEP-2 cells resulted in the same >90% HBG/(HBG+HBB) RNA level, as well as the same decrease in HBB RNA as depletion of MBD3. LRF depletion alone in WT HUDEP-2 cells also resulted in a significant decrease in HBB expression without a significant increase in HBG expression. This contrasts with the effect of mutation of the -198 LRF binding site in the HBG promoter, which results in high levels of HBG expression without a significant decrease in HBB expression ( Antoniou, etal, Nature Comm.,2022). Immunoprecipitation assays showed that LRF interacts with either MBD2-NuRD or MBD3-NuRD. These results are consistent with the fact that the repressive action of LRF, like that of BCL11A, requires association specifically with MBD2-NuRD to position a nucleosome and block the binding of a positive acting transcription factor, in this case GATA-1. Accordingly, disruption of MBD2-NuRD results in high level HBG expression while disruption of MBD3-NuRD does not, as we and others have shown. Conversely, LRF in association with MBD3-NuRD is required for maximum expression of the HBB gene in adult erythroid HUDEP-2 cells. Since combined disruption of the BCL11A-MBD2-NuRD complex and the LRF-MBD3-NuRD complex results in nearly 100% Hb F levels, these findings have implications for the treatment of sickle cell anemia, in which maximizing HbF levels while lowering HbS levels should provide the optimum protection from RBC sickling and its pathophysiologic consequences.
Disclosures: No relevant conflicts of interest to declare.